For an effective vaccine therapy, T-cell responses may be more important than antibody responses; therefore, detection of spontaneous T-cell responses in patients with ALK-positive NSCLC will be an important follow-up of this study. The gene discussed is ALK; the disease is non-small cell lung carcinoma.